等待开盘 12-19 09:30:00 美东时间
-1.360
-0.39%
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
今天 10:15
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and lowers the price target from $359 to $352.
今天 01:48
Scripps Sports has secured exclusive local broadcast rights to Denver Summit FC, the National Women’s Soccer League’s newest franchise launching in 2026. The agreement, spanning multiple years, will air all non-nationally exclusive matches on Denver7 (KMGH-TV) and The Spot Denver 3 (KCDO-TV). This deal complements Scripps Sports’ existing NWSL national partnership and reinforces its commitment to women’s professional sports, including coverage of...
12-18 21:15
A amendment with bipartisan support in the House that would extend enhanced ACA subsidies for another two years doesn't have support of Republican leadership. The amendment, which would include change...
12-16 07:23
Are health insurance stocks a buy, sell, or hold right now? Seeking Alpha analysts Stephen Ayers and Edmund Ingham weigh in. Stephen Ayers: In the current AI capital cycle, I believe that health insur...
12-15 05:35
Dueling pieces of health care legislation proposed by Republicans and Democrats both failed to pass on Thursday. The vote total for both bills was the same, 51-48. Sixty votes are needed in the Senate...
12-12 03:28
Mark Cuban slammed major insurers for mistreating independent doctors and argued that the Affordable Care Act has been overtaken by corporate abuse, saying the law is now "garbage" and must be replaced as Washington battles over the future of ACA subsidies.
12-05 13:00
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $380 to $400.
11-27 00:27
Trump prepares a health care plan proposing an ACA subsidy extension, new eligibility caps and measures to counter premium spikes as year-end deadlines approach.
11-24 23:44
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.
11-18 03:27